These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20878507)

  • 21. Reevaluating therapies for bipolar depression.
    Grunze H
    J Clin Psychiatry; 2005; 66 Suppl 5():17-25. PubMed ID: 16038598
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacotherapy of depression and mixed states in bipolar disorder.
    Montgomery SA; Schatzberg AF; Guelfi JD; Kasper S; Nemeroff C; Swann A; Zajecka J
    J Affect Disord; 2000 Sep; 59 Suppl 1():S39-S56. PubMed ID: 11121826
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antidepressant dose and treatment response in bipolar depression: Reanalysis of the Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) data.
    Tada M; Uchida H; Mizushima J; Suzuki T; Mimura M; Nio S
    J Psychiatr Res; 2015 Sep; 68():151-6. PubMed ID: 26228414
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pharmacotherapy of bipolar depression: an update.
    Thase ME
    Curr Psychiatry Rep; 2006 Dec; 8(6):478-88. PubMed ID: 17094928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of manic switch associated with antidepressant therapy in pediatric bipolar depression.
    Bhowmik D; Aparasu RR; Rajan SS; Sherer JT; Ochoa-Perez M; Chen H
    J Child Adolesc Psychopharmacol; 2014 Dec; 24(10):551-61. PubMed ID: 25470655
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bipolar depression and antidepressant-induced mania: a naturalistic study.
    Boerlin HL; Gitlin MJ; Zoellner LA; Hammen CL
    J Clin Psychiatry; 1998 Jul; 59(7):374-9. PubMed ID: 9714266
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Bipolar disorder and mechanisms of action of mood stabilizers.
    Rapoport SI; Basselin M; Kim HW; Rao JS
    Brain Res Rev; 2009 Oct; 61(2):185-209. PubMed ID: 19555719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bipolar disorder, not so rare diagnosis: subtypes of different degrees of severity, diagnosis, therapy.
    Amihăesei IC
    Rev Med Chir Soc Med Nat Iasi; 2014; 118(1):111-5. PubMed ID: 24741786
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of antidepressant continuation after acute positive or partial treatment response for bipolar depression: a blinded, randomized study.
    Altshuler LL; Post RM; Hellemann G; Leverich GS; Nolen WA; Frye MA; Keck PE; Kupka RW; Grunze H; McElroy SL; Sugar CA; Suppes T
    J Clin Psychiatry; 2009 Apr; 70(4):450-7. PubMed ID: 19358785
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A randomized trial comparing paroxetine and venlafaxine in the treatment of bipolar depressed patients taking mood stabilizers.
    Vieta E; Martinez-Arán A; Goikolea JM; Torrent C; Colom F; Benabarre A; Reinares M
    J Clin Psychiatry; 2002 Jun; 63(6):508-12. PubMed ID: 12088162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Bipolar depression: a review of current therapeutic strategies].
    Thuile J; Even C; Guelfi JD
    Encephale; 2006 Oct; 32(5 Pt 1):767-74. PubMed ID: 17099601
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Efficacy and safety of antidepressant's use in the treatment of depressive episodes in bipolar disorder - review of research.
    Antosik-Wójcińska AZ; Stefanowski B; Święcicki Ł
    Psychiatr Pol; 2015; 49(6):1223-39. PubMed ID: 26909398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Antidepressant discontinuation in bipolar depression: a Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD) randomized clinical trial of long-term effectiveness and safety.
    Ghaemi SN; Ostacher MM; El-Mallakh RS; Borrelli D; Baldassano CF; Kelley ME; Filkowski MM; Hennen J; Sachs GS; Goodwin FK; Baldessarini RJ
    J Clin Psychiatry; 2010 Apr; 71(4):372-80. PubMed ID: 20409444
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fluoxetine monotherapy of bipolar type II and bipolar NOS major depression: a double-blind, placebo-substitution, continuation study.
    Amsterdam JD; Shults J
    Int Clin Psychopharmacol; 2005 Sep; 20(5):257-64. PubMed ID: 16096516
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pharmacological management of bipolar depression: acute treatment, maintenance, and prophylaxis.
    Vieta E; Valentí M
    CNS Drugs; 2013 Jul; 27(7):515-29. PubMed ID: 23749421
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antidepressant-associated mood elevations in bipolar II disorder compared with bipolar I disorder and major depressive disorder: a systematic review and meta-analysis.
    Bond DJ; Noronha MM; Kauer-Sant'Anna M; Lam RW; Yatham LN
    J Clin Psychiatry; 2008 Oct; 69(10):1589-601. PubMed ID: 19192442
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The armamentarium of treatments for bipolar disorder: a review of the literature.
    Cousins DA; Young AH
    Int J Neuropsychopharmacol; 2007 Jun; 10(3):411-31. PubMed ID: 17176493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bipolar depression: pharmacotherapy and related therapeutic strategies.
    Thase ME; Sachs GS
    Biol Psychiatry; 2000 Sep; 48(6):558-72. PubMed ID: 11018227
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Treatments for late-life bipolar disorder.
    Aziz R; Lorberg B; Tampi RR
    Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.